Somatostatin Versus Octreotide for Prevention of Postoperative Pancreatic Fistula: The PREFIPS Randomized Clinical Trial: A FRENCH 007-ACHBT Study.
Gaujoux S, Regimbeau JM, Piessen G, Truant S, Foissac F, Barbier L, Buc E, Adham M, Fuks D, Deguelte S, Muscari F, Sulpice L, Vaillant JC, Schwarz L, Sa Cunha A, Muzzolini M, Dousset B, Sauvanet A; Collaborators.
Ann Surg. 2024 Aug 1;280(2):179-187. doi: 10.1097/SLA.0000000000006313. Epub 2024 Apr 25.
PMID:38662619
A new fistula risk score using sarcopenic obesity and subcutaneous fat area for predicting postoperative pancreatic fistula after pancreaticoduodenectomy.
Hayashi H, Shimizu A, Kubota K, Notake T, Masuo H, Yoshizawa T, Hosoda K, Sakai H, Ikehara T, Soejima Y.
Passaro ME, Broughan TA, Sebek BA, Esselstyn CB Jr.
J Am Coll Surg. 1994 Jan;178(1):29-32.
PMID:8156113
Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy.
Abe T, Amano H, Kobayashi T, Hanada K, Hattori M, Nakahara M, Ohdan H, Noriyuki T.
BMC Gastroenterol. 2020 Aug 8;20(1):264. doi: 10.1186/s12876-020-01397-7.